Cooperative Agreement NU58DP006369

The New Mexico Diabetes Advisory Council (NMDAC) will receive $599,288 under a Cooperative Agreement awarded by the Department of Health and Human Services Administration for Community Living (ACL) on May 1, 2023. The funding supports NMDAC's work to increase participation in chronic disease self-management education programs in New Mexico through April 30, 2027. Specifically, NMDAC will introduce the Program to Encourage Active, Rewarding Lives for Seniors (PEARLS) and expand existing...

Cooperative Agreement Summary Clemson University's Division of Research, in partnership with the University of Georgia Research Foundation, received a $350,000 cooperative agreement from the National Center for Chronic Disease Prevention and Health Promotion (Centers for Disease Control and Prevention) under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988) awarded September 30, 2025, with completion scheduled for September 29, 2028. The project, "Evaluating the...

Federal Cooperative Agreement Award Summary The University of Utah's Office of Sponsored Projects received a $996,369 Cooperative Agreement from the National Center for Chronic Disease Prevention and Health Promotion (Centers for Disease Control and Prevention) under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988) for the Enhanced Visibility, Engagement, and Reach of Lifestyle Change Interventions Project (EVER-LCI) and Lifestyle Change Interventions Research Network...

The National Science Foundation (NSF) awarded a $303,930 Project Grant under the Social, Behavioral, and Economic Sciences (CFDA 47.075) program to St. Mary's University of San Antonio, Texas. The grant funds a 3-year randomized controlled trial (RCT) to study the impact of enhanced diabetes care on workforce participation and economic outcomes among uninsured residents. The project partners with community stakeholders to provide additional diabetes education, supplies, and care management to...

Federal Project Grant Award Summary Scripps Health received a $165,541 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, with a completion date of July 31, 2030. This K01 Career Development Award supports Dr. San Diego's research to integrate continuous glucose monitoring (CGM) technology into diabetes self-management...

This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $167,864 to The General Hospital Corporation, doing business as Massachusetts General Hospital, to conduct a mixed-methods study on adapting and developing a diabetes self-management education and support (DSMES) intervention for people with type 2 diabetes experiencing food insecurity. The key objectives of the...

Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Regents of the University of Colorado (University of Colorado-Denver) a Project Grant of $756,480 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, effective September 5, 2025, through June 30, 2030, supports research to extend inferences of efficacy and selection of transformative diabetes therapies to diverse populations....

Federal Project Grant Award Summary Albert Einstein College of Medicine received a $183,558 Project Grant award effective March 1, 2026, through February 28, 2031, from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports implementation and evaluation of T1D-PATCHY (Type 1 Diabetes-Promoting Access to Diabetes Technology with Community Health Workers for Youth), a...

DYNAMO—Diabetes in Youth and Young Adults of the Pacific Northwest Seattle Children's Hospital, doing business as Seattle Children's Research Institute, received a $499,972 Cooperative Agreement from the National Center for Chronic Disease Prevention and Health Promotion under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988) effective September 30, 2025, with an ultimate completion date of September 29, 2029. The award supports the DYNAMO study, a multi-site research...

Cooperative Agreement Summary The University of Massachusetts Medical School received a Cooperative Agreement worth $999,986 from the National Center for Chronic Disease Prevention and Health Promotion (CDC) under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988) for the Lifestyle Change Implementation Research Network at the Prevention Research Center (PRC). The award, effective September 30, 2025, through September 29, 2027, supports research and implementation...